Rich Pharmaceuticals, Inc. Contracts & Agreements

90 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Plan of Conversion
Rich Pharmaceuticals, Inc.
Biotechnology
WY
2018
Asset Assignment Agreement dated June 11, 2019 with Richard L. Chang Holdings LLC
Assignment Agreements
Rich Pharmaceuticals, Inc.
2019
Asset Licensing Agreement dated June 11, 2019 with Geopulse Exploration, Inc
Rich Pharmaceuticals, Inc.
Biotechnology
2019
Promissory Note dated June 19, 2019 with Richard L. Chang Holdings LLC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2019
Promissory Note dated June 19, 2019 with SD Law Group APC
Note Agreements
Rich Pharmaceuticals, Inc.
2019
RICH PHARMACEUTICALS, INC. 2019 STOCK OPTION/STOCK ISSUANCE PLAN Article One GENERAL PROVISIONS
Stock Agreements
Rich Pharmaceuticals, Inc.
2019
Securities Purchase Agreement dated March 15, 2018 with GHS Investments, LLC
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2018
Promissory Note dated March 15, 2018 in favor of GHS Investments, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement dated January 10, 2018 with GHS Investments, LLC
Purchase Agreements
Rich Pharmaceuticals, Inc.
2018
Promissory Note dated January 10, 2018 in favor of GHS Investments, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2018
Ben Chang Employment Extension 2017
Employment Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2017
Securities Purchase Agreement dated November 3, 2017 with GHS Investments, LLC
Purchase Agreements
Rich Pharmaceuticals, Inc.
2017
Promissory Note dated November 3, 2017 in favor of GHS Investments, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Support and Collaboration Agreement dated July 11, 2017 with Mega Bridge, Inc
Collaboration Agreements
Rich Pharmaceuticals, Inc.
2017
2017 Stock Option/Stock Issuance Plan
Stock Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
CA
2017
Securities Purchase Agreement dated April 18, 2017 with GHS Investments, LLC
Purchase Agreements
Rich Pharmaceuticals, Inc.
2017
Promissory Note dated April 18, 2017 in favor of GHS Investments, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
2017
2017 Stock Option/Stock Issuance Plan
Stock Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
CA
2017
Collaboration Agreement dated March 20, 2017 with I Tech Health Corp
Collaboration Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NV
2017
Debt Purchase Agreement dated February 17, 2017 with GHS Investments, LLC
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Promissory Note in the amount of $563,027 dated February 17, 2017 in favor of GHS Investments, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Promissory Note in the amount of $20,899.89 dated February 22, 2017 with GHS Investments, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
2017
Promissory Note in the amount of $59,799.12 dated February 22, 2017 with GHS Investments, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
2017
Equity Financing Agreement dated February 22, 2017 with GHS Investments, LLC
Financing Agreements
Rich Pharmaceuticals, Inc.
2017
Registration Rights Agreement dated February 22, 2017 with GHS Investments, LLC
Registration Rights Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2017
Promissory Note in the amount of $20,000 dated February 22, 2017 with GHS Investments, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NV
2017
Promissory Note in the amount of $15,000 dated February 22, 2017 with GHS Investments, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
2017
Securities Purchase Agreement dated January 5, 2017 with GHS Investments, LLC
Purchase Agreements
Rich Pharmaceuticals, Inc.
2017
Promissory Note dated January 5, 2017 in favor of GHS Investments, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
2017
Securities Purchase Agreement dated October 20, 2016 with LG Capital Funding, LLC
Purchase Agreements
Rich Pharmaceuticals, Inc.
2016
8% Convertible Redeemable Promissory Note dated October 20, 2016 with LG Capital Funding, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
2016
Confession of Judgement dated October 20, 2016
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Securities Purchase Agreement dated June 23, 2016 with LG Capital Funding, LLC
Purchase Agreements
Rich Pharmaceuticals, Inc.
2016
8% Convertible Redeemable Promissory Note dated June 23, 2016 with LG Capital Funding, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
8% Convertible Redeemable Promissory Note dated June 23, 2016 with LG Capital Funding, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
2016
Collateralized Secured Promissory Note dated June 23, 2016 issued by LG Capital Funding, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Confession of Judgement dated June 23, 2016
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Securities Purchase Agreement dated June 8, 2016 with LG Capital Funding, LLC
Purchase Agreements
Rich Pharmaceuticals, Inc.
2016
8% Convertible Redeemable Promissory Note dated June 8, 2016 with LG Capital Funding, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
2016
8% Convertible Redeemable Promissory Note dated June 8, 2016 with LG Capital Funding, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Collateralized Secured Promissory Note dated June 8, 2016 issued by LG Capital Funding, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
2016
Secured Promissory Note dated May 31, 2016 with Computerlaw Group, LLP
Note Agreements
Rich Pharmaceuticals, Inc.
2016
2013 Plan Amendment No. 3
Rich Pharmaceuticals, Inc.
Biotechnology
2015
Employment Agreement, dated August 4, 2015 with Richard Salvador
Employment Agreements
Rich Pharmaceuticals, Inc.
2015
Amended and Restated Investment Agreement dated May 19, 2015 with LG Capital Funding , LLC
Funding Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2015
Securities Purchase Agreement dated May 27, 2015 with Typenex Co-Investment, LLC
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
UT
2015
Secured Convertible Promissory Note dated May 27, 2015 with Typenex Co-Investment, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
UT
2015
Security Agreement dated May 27, 2015 with Typenex Co-Investment, LLC
Security Agreements
Rich Pharmaceuticals, Inc.
2015
Form of Secured Investor Note
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
UT
2015
Investment Agreement dated May 19, 2015 with LG Capital Funding , LLC
Funding Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2015
Securities Purchase Agreement with LG Capital Funding dated May 5, 2015
Purchase Agreements
Rich Pharmaceuticals, Inc.
2015
Convertible Promissory Note with LG Capital Funding dated May 5, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
2015
Back-End Convertible Promissory Note with LG Capital Funding dated May 5, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
2015
Collateralized Secured Promissory Note with LG Capital Funding dated May 5, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2015
Convertible Promissory Note with Vis Veres Group, Inc. dated May 6, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
2015
2013 Plan Amendment No. 2
Rich Pharmaceuticals, Inc.
Biotechnology
2015
Securities Purchase Agreement dated March 26, 2015 with Adar Bays, LLC
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2015
Convertible Promissory Note dated March 26, 2015 with Adar Bays, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
2015
Back-End Convertible Promissory Note with Adar Bays, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
2015
Adar Bays, LLC Collateralized Secured Promissory Note dated March 26, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
2015
Securities Purchase Agreement dated March 9, 2015 with Auctus Private Equity Fund, LLC
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
MA
2015
Convertible Promissory Note dated March 9, 2015 with Auctus Private Equity Fund, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
MA
2015
Convertible Promissory Note dated February 5, 2015 issued to KBM Worldwide, Inc
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2015
Convertible Promissory Note dated January 9, 2015 with KBM Worldwide, Inc
Note Agreements
Rich Pharmaceuticals, Inc.
2015
Convertible Promissory Note dated November 25, 2014 with KBM Worldwide, Inc
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014
Convertible Promissory Note dated October 6, 3014 issued to KBM Worldwide, Inc
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014
Convertible Promissory Note dated November 6, 2014 with JSJ Investments, Inc
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
TX
2014
Assignment Agreement dated October 6, 2014
Assignment Agreements
Rich Pharmaceuticals, Inc.
2014
2013 Plan Amendment dated October 6, 2014
Rich Pharmaceuticals, Inc.
2014
Master Convertible Promissory Note dated September 18, 2014 with Typenex Co-Investment LLC, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
2014
Securities Purchase Agreement dated September 23, 2014 with Auctus Private Equity Fund, LLC
Purchase Agreements
Rich Pharmaceuticals, Inc.
2014
Convertible Promissory Note dated September 23, 2014 with Auctus Private Equity Fund, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
MA
2014
Convertible Promissory Note with KBM Worldwide, Inc. dated April 8, 2014 in the amount of $53,000
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014
Convertible Promissory Note with KBM Worldwide, Inc. dated May 21, 2014 in the amount of $42,500
Note Agreements
Rich Pharmaceuticals, Inc.
2014
Investment Agreement dated August 12, 2014 with Macallan Partners
Investment Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014
Registration Rights Agreement dated August 12, 2014 with Macallan Partners
Registration Rights Agreements
Rich Pharmaceuticals, Inc.
2014
Convertible Promissory Note dated August 12, 2014 with JMJ Financial
Note Agreements
Rich Pharmaceuticals, Inc.
2014
Securities Purchase Agreement dated August 14, 2014 with Toledo Advisors LLC
Purchase Agreements
Rich Pharmaceuticals, Inc.
2014
First Convertible Promissory Note dated August 14, 2014 with Toledo Advisors
Note Agreements
Rich Pharmaceuticals, Inc.
2014
Second Convertible Promissory Note dated August 14, 2014 with Toledo Advisors LLC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2014
Securities Purchase Agreement dated August 14, 2014 with LG Capital Funding, LLC
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014
First Convertible Promissory Note dated August 14, 2014 with LG Capital Funding, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
2014
Second Convertible Promissory Note dated August 14, 2014 with LG Capital Funding, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2014
Convertible Promissory Note dated August 14, 2014 with Vista Capital Investments, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
CA
2014
Convertible Promissory Note with Asher Enterprises, Inc
Note Agreements
Rich Pharmaceuticals, Inc.
2014
Waiver to Memorandum of Understanding and Asset Assignment Agreement dated January 17, 2014
Waiver Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2014
Employment Agreement with Ben Chang dated September 6, 2013
Employment Agreements
Rich Pharmaceuticals, Inc.
2013
2013 Stock Option/Stock Issuance Plan
Stock Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
CA
2013
Agreement of Conveyance, Transfer and Assignment of Assets and Assumption of Obligations, dated July 19, 2013
Assignment Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NV
2013
Assignment Agreement, dated July 18, 2013
Assignment Agreements
Rich Pharmaceuticals, Inc.
2013